You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
| Title |
Lenalidomide in heavily pretreated refractory diffuse large B-cell lymphoma: a case report
|
|---|---|
| Published in |
Journal of Medical Case Reports, October 2014
|
| DOI | 10.1186/1752-1947-8-325 |
| Pubmed ID | |
| Authors |
Katarzyna Krawczyk, Wojciech Jurczak, Krystyna Gałązka, Andrzej Gruchała, Aleksander B Skotnicki |
| Abstract |
In diffuse large B-cell lymphoma, first-line treatment with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone; salvage with cisplatin-based regimens for relapsing patients; and autologous stem cell therapy are standards of care. Treatment approaches are less clear for patients who are refractory or who are not candidates for autologous stem cell therapy. Options may include palliative regimens or clinical trial enrollment. One therapy under investigation in diffuse large B-cell lymphoma is lenalidomide, an immunomodulatory agent with antiangiogenic activity. |
Mendeley readers
The data shown below were compiled from readership statistics for 20 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 20 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 5 | 25% |
| Researcher | 3 | 15% |
| Other | 2 | 10% |
| Professor | 1 | 5% |
| Student > Doctoral Student | 1 | 5% |
| Other | 2 | 10% |
| Unknown | 6 | 30% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 10 | 50% |
| Business, Management and Accounting | 1 | 5% |
| Immunology and Microbiology | 1 | 5% |
| Computer Science | 1 | 5% |
| Unknown | 7 | 35% |